In order to thrive, you need to have all of the tools at your fingertips, and that includes evidence-based therapies that go beyond conventional oncology.
Download our FREE PDF guide filled with evidence-based therapies that you can start today to manage your Pancreatic Cancer. Click the orange button to get your download now.
If you have been diagnosed with pancreatic cancer (PC) your first challenge is to deal with your oncologist telling you that little if anything can be done to fight pancreatic cancer. What he/she means is only that there is little that conventional oncology can offer as PC therapy.
As you can read from the articles linked and excerpted below, green tea (EGCG) kills PC. Further, there are several evidence-based antioxidants that have been shown to work synergistically with chemotherapy to also kill PC.
To take integrative and/or complementary therapies further, consider curcumin enhancing gemcitabine. Or ellagic acid also killing PC. My point is, PC patients must think outside the conventional chemo box.
I am a long-term survivor of incurable cancer called multiple myeloma. Myeloma is incurable if the patient chooses to remain in the conventional oncology world. Like PC there are many evidence-based non-conventional therapies to pursue.
No, I am not offering a silver bullet. Make no mistake, PC is a complicated, difficult cancer to manage. All I am saying is that conventional oncology doesn’t offer much hope.
Please take a moment to watch the short video below in order to learn more about evidence-based therapies:
Have you been diagnosed with PC? Scroll down the page, post a question or comment and I will reply to you ASAP.
“Epigallocatechin-3-gallate (EGCG) is the main polyphenolic constituent in green tea and is believed to function as an antioxidant. However, increasing evidence indicates that EGCG produces reactive oxygen species (ROS) and subsequent cell death. In this study, we investigated the prooxidative effects of EGCG on the HIT-T15 pancreatic beta cell line…
Treatment with EGCG (5-100 microM) decreased the viability of pancreatic beta cells, caused concomitant increases in apoptotic cell death, and increased the production of H(2)O(2) and ROS…
Together, these findings suggest that in the HIT-T15 pancreatic beta cell line, EGCG mediated the generation of H(2)O(2), triggering Fe(II)-dependent formation of a highly toxic radical that in turn induced oxidative cell damage.”
“Reported in the journal Metabolomics, the study explores the effect of epigallocatechin gallate or “EGCG,” an active biological agent of green tea. It shows that EGCG changes the metabolism of pancreatic cancer cells by suppressing the expression of lactate dehydrogenase A or LDHA, a critical enzyme in cancer metabolism…”
“A number of preclinical studies have demonstrated anticancer effects for curcumin in various types of tumors, including pancreatic cancer. Curcumin has anticancer effects both alone and in combination with other anticancer drugs (e.g., gemcitabine, 5-fluorouracil, and oxaliplatin), and it has been shown to modulate a variety of molecular targets in preclinical models, with more than 30 molecular targets identified to date.
Of these various molecules, NF-κB is thought to be one of the primary targets of curcumin activity. Based on these promising preclinical results, several research groups, including our own, have progressed to testing the anticancer effects of curcumin in clinical trials; however, the poor bioavailability of this agent has been the major challenge for its clinical application.
In this article, we review possible therapeutic applications of curcumin in patients with pancreatic cancer…”